The matricellular receptor lrp1 forms an interface for signaling and endocytosis in modulation of the extracellular tumor environment

Frontiers in Pharmacology

Volumn 6, Issue NOV, 2015, Pages

  Van Gool, Bart ^a   Dedieu, Stéphane ^b   Emonard, Hervé ^b   Roebroek, Anton J M ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

Cancer; Endocytosis; Extracellular matrix; LRP1; Metastasis; Signaling

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

ARTICLE; BLOOD BRAIN BARRIER; CANCER GROWTH; CARCINOGENESIS; DISEASE ACTIVITY; DISEASE MARKER; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; HUMAN; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR PATHOLOGY; NONHUMAN; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84949783250     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2015.00271     Document Type: Article

References (88)

1. Amos, S., Mut, M., diPierro, C. G., Carpenter, J. E., Xiao, A., Kohutek, Z. A., et al. (2007). Protein kinase C-a-mediated regulation of low-density lipoprotein receptor related protein and urokinase increases astrocytoma invasion. Cancer Res. 67, 10241-10251. doi: 10.1158/0008-5472.CAN-07-0030
2. Andersen, O. M., Christensen, P. A., Christensen, L. L., Jacobsen, C., Moestrup, S. K., Etzerodt, M., et al. (2000). Specific binding of a-macroglobulin to complement-type repeat CR4 of the low-density lipoprotein receptor-related protein. Biochemistry 39, 10627-10633. doi: 10.1021/bi000498h
3. Baietti, M. F., Zhang, Z., Mortier, E., Melchior, A., Degeest, G., Geeraerts, A., et al. (2012). Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat. Cell Biol. 14, 677-685. doi: 10.1038/ncb2502
4. Baum, L., Dong, Z. Y., Choy, K. W., Pang, C. P., and Ng, H. K. (1998). Low density lipoprotein receptor related protein gene amplification and 766T polymorphism in astrocytomas. Neurosci. Lett. 256, 5-8. doi: 10.1016/S0304-3940(98)00734-4
5. Beaujouin, M., Prebois, C., Derocq, D., Laurent-Matha, V., Masson, O., Pattingre, S., et al. (2010). Pro-cathepsin D interacts with the extracellular domain of the β chain of LRP1 and promotes LRP1-dependent fibroblast outgrowth. J. Cell Sci. 123(Pt 19), 3336-3346. doi: 10.1242/jcs.070938
6. Benes, P., Jurajda, M., Zaloudík, J., Izakovicová-Hollá, L., and Vácha, J. (2003). C766T low-density lipoprotein receptor-related protein 1 (LRP1) gene polymorphism and susceptibility to breast cancer. Breast Cancer Res. 5, R77-R81. doi: 10.1186/bcr591
7. Benes, P., Muzik, J., Benedik, J., Elbl, L., Vasku, A., Siskova, L., et al. (2001). The C766T low-density lipoprotein receptor related protein polymorphism and coronary artery disease, plasma lipoproteins, and longevity in the Czech population. J. Mol. Med. (Berl.) 79, 116-120. doi: 10.1007/s001090100196
8. Bertrand, Y., Currie, J. C., Poirier, J., Demeule, M., Abulrob, A., Fatehi, D., et al. (2011). Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1. Br. J. Cancer 105, 1697-1707. doi: 10.1038/bjc.2011.427
9. Boucher, P., Liu, P., Gotthardt, M., Hiesberger, T., Anderson, R. G., and Herz, J. (2002). Platelet-derived growth factor mediates tyrosine phosphorylation of the cytoplasmic domain of the low density lipoprotein receptor-related protein in caveolae. J. Biol. Chem. 277, 15507-15513. doi: 10.1074/jbc. M200428200
10. Catasus, L., Llorente-Cortes, V., Cuatrecasas, M., Pons, C., Espinosa, I., and Prat, J. (2011). Low-density lipoprotein receptor-related protein 1 (LRP-1) is associated with highgrade, advanced stage and p53 and p16 alterations in endometrial carcinomas. Histopathology 59, 567-571. doi: 10.1111/j.1365-2559.2011.03942.x
11. Chazaud, B., Ricoux, R., Christov, C., Plonquet, A., Gherardi, R. K., and Barlovatz-Meimon, G. (2002). Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations. Am. J. Pathol. 160, 237-246. doi: 10.1016/S0002-9440(10)64367-2
12. Czekay, R. P., Kuemmel, T. A., Orlando, R. A., and Farquhar, M. G. (2001). Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity. Mol. Biol. Cell 12, 1467-1479. doi: 10.1091/mbc.12.5.1467
13. Dedieu, S., Langlois, B., Devy, J., Sid, B., Henriet, P., Sartelet, H., et al. (2008). LRP-1 silencing prevents malignant cell invasion despite increased pericellular proteolytic activities. Mol. Cell. Biol. 28, 2980-2995. doi: 10.1128/MCB.02238-07
14. Derocq, D., Prebois, C., Beaujouin, M., Laurent-Matha, V., Pattingre, S., Smith, G. K., et al. (2012). Cathepsin D is partly endocytosed by the LRP1 receptor and inhibits LRP1-regulated intramembrane proteolysis. Oncogene 31, 3202-3212. doi: 10.1038/onc.2011.501
15. De Toro, J., Herschlik, L., Waldner, C., and Mongini, C. (2015). Emerging roles of exosomes in normal and pathological conditions: new insights for diagnosis and therapeutic applications. Front. Immunol. 6:203. doi: 10.3389/fimmu.2015.00203
16. de Vries, T. J., Verheijen, J. H., de Bart, A. C., Weidle, U. H., Ruiter, D. J., and van Muijen, G. N. (1996). Decreased expression of both the low-density lipoprotein receptor-related protein/a2-macroglobulin receptor and its receptor-associated protein in late stages of cutaneous melanocytic tumor progression. Cancer Res. 56, 1432-1439.
17. Drappatz, J., Brenner, A., Wong, E. T., Eichler, A., Schiff, D., Groves, M. D., et al. (2013). Phase I study of GRN1005 in recurrent malignant glioma. Clin. Cancer Res. 19, 1567-1576. doi: 10.1158/1078-0432.CCR-12-2481
18. Egea, V., Zahler, S., Rieth, N., Neth, P., Popp, T., Kehe, K., et al. (2012). Tissue inhibitor of metalloproteinase-1 (TIMP-1) regulates mesenchymal stem cells through let-7f microRNA and Wnt/β-catenin signaling. Proc. Natl. Acad. Sci. U.S.A. 109, E309-E316. doi: 10.1073/pnas.1115083109
19. Emonard, H., Bellon, G., de Diesbach, P., Mettlen, M., Hornebeck, W., and Courtoy, P. J. (2005). Regulation of matrix metalloproteinase (MMP) activity by the low-density lipoprotein receptor-related protein (LRP). A new function for an "old friend". Biochimie 87, 369-376. doi: 10.1016/j.biochi.2004.11.013
20. Etique, N., Verzeaux, L., Dedieu, S., and Emonard, H. (2013). LRP-1: a checkpoint for the extracellular matrix proteolysis. Biomed. Res. Int. 2013, 152163. doi: 10.1155/2013/152163
21. Fayard, B., Bianchi, F., Dey, J., Moreno, E., Djaffer, S., Hynes, N. E., et al. (2009). The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression. Cancer Res. 69, 5690-5698. doi: 10.1158/0008-5472.CAN-08-4573
22. Gilardoni, M. B., Ceschin, D. G., Sahores, M. M., Oviedo, M., Gehrau, R. C., and Chiabrando, G. A. (2003). Decreased expression of the low-density lipoprotein receptor-related protein-1 (LRP-1) in rats with prostate cancer. J. Histochem. Cytochem. 51, 1575-1580. doi: 10.1177/002215540305101201
23. Gonias, S. L., Gaultier, A., and Jo, M. (2011). Regulation of the urokinase receptor (uPAR) by LDL receptor-related protein-1 (LRP1). Curr. Pharm. Des. 17, 1962-1969. doi: 10.2174/138161211796718224
24. Gordts, P. L., Bartelt, A., Nilsson, S. K., Annaert, W., Christoffersen, C., Nielsen, L. B., et al. (2012). Impaired LDL receptor-related protein 1 translocation correlates with improved dyslipidemia and atherosclerosis in apoE-deficient mice. PLoS ONE 7:e38330. doi: 10.1371/journal.pone.0038330
25. Gordts, P. L., Reekmans, S., Lauwers, A., Van Dongen, A., Verbeek, L., and Roebroek, A. J. (2009). Inactivation of the LRP1 intracellular NPxYxxL motif in LDLR-deficient mice enhances postprandial dyslipidemia and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 29, 1258-1264. doi: 10.1161/ATVBAHA.109.192211
26. Greenaway, J., Lawler, J., Moorehead, R., Bornstein, P., Lamarre, J., and Petrik, J. (2007). Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1). J. Cell. Physiol. 210, 807-818. doi: 10.1002/jcp.20904
27. Herz, J., Hamann, U., Rogne, S., Myklebost, O., Gausepohl, H., and Stanley, K. K. (1988). Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J. 7, 4119-4127.
28. Huang, X. Y., Shi, G. M., Devbhandari, R. P., Ke, A. W., Wang, Y., Wang, X. Y., et al. (2012). Low level of low-density lipoprotein receptor-related protein 1 predicts an unfavorable prognosis of hepatocellular carcinoma after curative resection. PLoS ONE 7:e32775. doi: 10.1371/journal.pone.0032775
29. Ilan, N., Elkin, M., and Vlodavsky, I. (2006). Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis. Int. J. Biochem. Cell Biol. 38, 2018-2039. doi: 10.1016/j.biocel.2006.06.004
30. Jensen, P. H., Ebbesen, P., and Gliemann, J. (1989). Low a2-macroglobulin-proteinase complex binding: a common but not exclusive characteristic of malignant cells. In Vivo 3, 7-9.
31. Jovcevska, I., Kocevar, N., and Komel, R. (2013). Glioma and glioblastoma-how much do we (not) know? Mol. Clin. Oncol. 1, 935-941. doi: 10.3892/mco.2013.172
32. Kancha, R. K., Stearns, M. E., and Hussain, M. M. (1994). Decreased expression of the low density lipoprotein receptor-related protein/a2-macroglobulin receptor in invasive cell clones derived from human prostate and breast tumor cells. Oncol. Res. 6, 365-372.
33. Kanekiyo, T., and Bu, G. (2014). The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer's disease. Front. Aging Neurosci. 6:93. doi: 10.3389/fnagi.2014.00093
34. Kessenbrock, K., Plaks, V., and Werb, Z. (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141, 52-67. doi: 10.1016/j.cell.2010.03.015
35. Kessenbrock, K., Wang, C. Y., and Werb, Z. (2015). Matrix metalloproteinases in stem cell regulation and cancer. Matrix Biol. 44-46, 184-190. doi: 10.1016/j.matbio.2015.01.022
36. Kolsch, H., Ptok, U., Mohamed, I., Schmitz, S., Rao, M. L., Maier, W., et al. (2003). Association of the C766T polymorphism of the low-density lipoprotein receptor-related protein gene with Alzheimer's disease. Am. J. Med. Genet. B Neuropsychiatr. Genet. 121b, 128-130. doi: 10.1002/ajmg.b.20043
37. Kurzrock, R., Gabrail, N., Chandhasin, C., Moulder, S., Smith, C., Brenner, A., et al. (2012). Safety, pharmacokinetics, and activity of GRN1005, a novel conjugate of angiopep-2, a peptide facilitating brain penetration, and paclitaxel, in patients with advanced solid tumors. Mol. Cancer Ther. 11, 308-316. doi: 10.1158/1535-7163.MCT-11-0566
38. Laurent-Matha, V., Huesgen, P. F., Masson, O., Derocq, D., Prebois, C., Gary-Bobo, M., et al. (2012). Proteolysis of cystatin C by cathepsin D in the breast cancer microenvironment. FASEB J. 26, 5172-5181. doi: 10.1096/fj.12-205229
39. Li, Y., Marzolo, M. P., van Kerkhof, P., Strous, G. J., and Bu, G. (2000). The YXXL motif, but not the two NPXY motifs, serves as the dominant endocytosis signal for low density lipoprotein receptor-related protein. J. Biol. Chem. 275, 17187-17194. doi: 10.1074/jbc. M000490200
40. Lillis, A. P., Van Duyn, L. B., Murphy-Ullrich, J. E., and Strickland, D. K. (2008). LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol. Rev. 88, 887-918. doi: 10.1152/physrev.00033.2007
41. Liu, X. W., Bernardo, M. M., Fridman, R., and Kim, H. R. (2003). Tissue inhibitor of metalloproteinase-1 protects human breast epithelial cells against intrinsic apoptotic cell death via the focal adhesion kinase/phosphatidylinositol 3-kinase and MAPK signaling pathway. J. Biol. Chem. 278, 40364-40372. doi: 10.1074/jbc. M302999200
42. Loukinova, E., Ranganathan, S., Kuznetsov, S., Gorlatova, N., Migliorini, M. M., Loukinov, D., et al. (2002). Platelet-derived growth factor (PDGF)-induced tyrosine phosphorylation of the low density lipoprotein receptor-related protein (LRP). Evidence for integrated co-receptor function between LRP and the PDGF. J. Biol. Chem. 277, 15499-15506. doi: 10.1074/jbc. M200427200
43. Maletinska, L., Blakely, E. A., Bjornstad, K. A., Deen, D. F., Knoff, L. J., and Forte, T. M. (2000). Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein. Cancer Res. 60, 2300-2303.
44. Martin, A. M., Kuhlmann, C., Trossbach, S., Jaeger, S., Waldron, E., Roebroek, A., et al. (2008). The functional role of the second NPXY motif of the LRP1 β-chain in tissue-type plasminogen activator-mediated activation of N-methyl-D-aspartate receptors. J. Biol. Chem. 283, 12004-12013. doi: 10.1074/jbc. M707607200
45. Martinez-Ledesma, E., Verhaak, R. G., and Trevino, V. (2015). Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm. Sci. Rep. 5, 11966. doi: 10.1038/srep11966
46. May, P., Reddy, Y. K., and Herz, J. (2002). Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. J. Biol. Chem. 277, 18736-18743. doi: 10.1074/jbc. M201979200
47. May, P., Rohlmann, A., Bock, H. H., Zurhove, K., Marth, J. D., Schomburg, E. D., et al. (2004). Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice. Mol. Cell. Biol. 24, 8872-8883. doi: 10.1128/MCB.24.20.8872-8883.2004
48. Meng, H., Chen, G., Zhang, X., Wang, Z., Thomas, D. G., Giordano, T. J., et al. (2011). Stromal LRP1 in lung adenocarcinoma predicts clinical outcome. Clin. Cancer Res. 17, 2426-2433. doi: 10.1158/1078-0432.CCR-10-2385
49. Montel, V., Gaultier, A., Lester, R. D., Campana, W. M., and Gonias, S. L. (2007). The low-density lipoprotein receptor-related protein regulates cancer cell survival and metastasis development. Cancer Res. 67, 9817-9824. doi: 10.1158/0008-5472.CAN-07-0683
50. Muratoglu, S. C., Mikhailenko, I., Newton, C., Migliorini, M., and Strickland, D. K. (2010). Low density lipoprotein receptor-related protein 1 (LRP1) forms a signaling complex with platelet-derived growth factor receptor-β in endosomes and regulates activation of the MAPK pathway. J. Biol. Chem. 285, 14308-14317. doi: 10.1074/jbc. M109.046672
51. Nakajima, C., Haffner, P., Goerke, S. M., Zurhove, K., Adelmann, G., Frotscher, M., et al. (2014). The lipoprotein receptor LRP1 modulates sphingosine-1-phosphate signaling and is essential for vascular development. Development 141, 4513-4525. doi: 10.1242/dev.109124
52. Newton, C. S., Loukinova, E., Mikhailenko, I., Ranganathan, S., Gao, Y., Haudenschild, C., et al. (2005). Platelet-derived growth factor receptor-β (PDGFR-β) activation promotes its association with the low density lipoprotein receptor-related protein (LRP). Evidence for co-receptor function. J. Biol. Chem. 280, 27872-27878. doi: 10.1074/jbc. M505410200
53. Obermeyer, K., Krueger, S., Peters, B., Falkenberg, B., Roessner, A., and Rocken, C. (2007). The expression of low density lipoprotein receptor-related protein in colorectal carcinoma. Oncol. Rep. 17, 361-367. doi: 10.3892/or.17.2.361
54. Orian-Rousseau, V. (2015). CD44 acts as a signaling platform controlling tumor progression and metastasis. Front. Immunol. 6:154. doi: 10.3389/fimmu.2015.00154
55. Pencheva, N., Tran, H., Buss, C., Huh, D., Drobnjak, M., Busam, K., et al. (2012). Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell 151, 1068-1082. doi: 10.1016/j.cell.2012.10.028
56. Perrot, G., Langlois, B., Devy, J., Jeanne, A., Verzeaux, L., Almagro, S., et al. (2012). LRP-1-CD44, a new cell surface complex regulating tumor cell adhesion. Mol. Cell. Biol. 32, 3293-3307. doi: 10.1128/MCB.00228-12
57. Pflanzner, T., Janko, M. C., Andre-Dohmen, B., Reuss, S., Weggen, S., Roebroek, A. J., et al. (2011). LRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier. Neurobiol. Aging 32, 2323.e1-2323.e11. doi: 10.1016/j.neurobiolaging.2010.05.025
58. Pietrzik, C. U., Yoon, I. S., Jaeger, S., Busse, T., Weggen, S., and Koo, E. H. (2004). FE65 constitutes the functional link between the low-density lipoprotein receptor-related protein and the amyloid precursor protein. J. Neurosci. 24, 4259-4265. doi: 10.1523/JNEUROSCI.5451-03.2004
59. Pocathikorn, A., Granath, B., Thiry, E., Van Leuven, F., Taylor, R., and Mamotte, C. (2003). Influence of exonic polymorphisms in the gene for LDL receptor-related protein (LRP) on risk of coronary artery disease. Atherosclerosis 168, 115-121. doi: 10.1016/S0021-9150(03)00087-X
60. Pritchard, A., Harris, J., Pritchard, C. W., St Clair, D., Lemmon, H., Lambert, J. C., et al. (2005). Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease. Neurosci. Lett. 382, 221-226. doi: 10.1016/j.neulet.2005.03.016
61. Quinn, K. A., Grimsley, P. G., Dai, Y. P., Tapner, M., Chesterman, C. N., and Owensby, D. A. (1997). Soluble low density lipoprotein receptor-related protein (LRP) circulates in human plasma. J. Biol. Chem. 272, 23946-23951. doi: 10.1074/jbc.272.38.23946
62. Raghu, H., Lakka, S. S., Gondi, C. S., Mohanam, S., Dinh, D. H., Gujrati, M., et al. (2010). Suppression of uPA and uPAR attenuates angiogenin mediated angiogenesis in endothelial and glioblastoma cell lines. PLoS ONE 5:e12458. doi: 10.1371/journal.pone.0012458
63. Ranganathan, S., Cao, C., Catania, J., Migliorini, M., Zhang, L., and Strickland, D. K. (2011). Molecular basis for the interaction of low density lipoprotein receptor-related protein 1 (LRP1) with integrin aMβ2: identification of binding sites within aMβ2 for LRP1. J. Biol. Chem. 286, 30535-30541. doi: 10.1074/jbc. M111.265413
64. Reekmans, S. M., Pflanzner, T., Gordts, P. L., Isbert, S., Zimmermann, P., Annaert, W., et al. (2010). Inactivation of the proximal NPXY motif impairs early steps in LRP1 biosynthesis. Cell. Mol. Life Sci. 67, 135-145. doi: 10.1007/s00018-009-0171-7
65. Regina, A., Demeule, M., Tripathy, S., Lord-Dufour, S., Currie, J. C., Iddir, M., et al. (2015). ANG4043, a novel brain-penetrant peptide-mAb conjugate, is efficacious against HER2-positive intracranial tumors in mice. Mol. Cancer Ther. 14, 129-140. doi: 10.1158/1535-7163.MCT-14-0399
66. Rehman, A. A., Ahsan, H., and Khan, F. H. (2013). a-2-Macroglobulin: a physiological guardian. J. Cell. Physiol. 228, 1665-1675. doi: 10.1002/jcp.24266
67. Roebroek, A. J., Reekmans, S., Lauwers, A., Feyaerts, N., Smeijers, L., and Hartmann, D. (2006). Mutant Lrp1 knock-in mice generated by recombinase-mediated cassette exchange reveal differential importance of the NPXY motifs in the intracellular domain of LRP1 for normal fetal development. Mol. Cell. Biol. 26, 605-616. doi: 10.1128/MCB.26.2.605-616.2006
68. Roucourt, B., Meeussen, S., Bao, J., Zimmermann, P., and David, G. (2015). Heparanase activates the syndecan-syntenin-ALIX exosome pathway. Cell Res. 25, 412-428. doi: 10.1038/cr.2015.29
69. Saksela, O., Wahlstrom, T., Lehtovirta, P., Seppala, M., and Vaheri, A. (1981). Presence of a2-macroglobulin in normal but not in malignant human syncytiotrophoblasts. Cancer Res. 41, 2507-2513.
70. Saksela, O., Wahlstrom, T., Meyer, B., and Vaheri, A. (1984). Presence of a2-macroglobulin in normal but not in malignant cervical epithelium. Cancer Res. 44, 2942-2946.
71. Salicioni, A. M., Gaultier, A., Brownlee, C., Cheezum, M. K., and Gonias, S. L. (2004). Low density lipoprotein receptor-related protein-1 promotes β1 integrin maturation and transport to the cell surface. J. Biol. Chem. 279, 10005-10012. doi: 10.1074/jbc. M306625200
72. Sauer, H., Ravindran, F., Beldoch, M., Sharifpanah, F., Jedelska, J., Strehlow, B., et al. (2013). a2-Macroglobulin enhances vasculogenesis/angiogenesis of mouse embryonic stem cells by stimulation of nitric oxide generation and induction of fibroblast growth factor-2 expression. Stem Cells Dev. 22, 1443-1454. doi: 10.1089/scd.2012.0640
73. Scilabra, S. D., Troeberg, L., Yamamoto, K., Emonard, H., Thogersen, I., Enghild, J. J., et al. (2013). Differential regulation of extracellular tissue inhibitor of metalloproteinases-3 levels by cell membrane-bound and shed low density lipoprotein receptor-related protein 1. J. Biol. Chem. 288, 332-342. doi: 10.1074/jbc. M112.393322
74. Staudt, N. D., Jo, M., Hu, J., Bristow, J. M., Pizzo, D. P., Gaultier, A., et al. (2013). Myeloid cell receptor LRP1/CD91 regulates monocyte recruitment and angiogenesis in tumors. Cancer Res. 73, 3902-3912. doi: 10.1158/0008-5472.CAN-12-4233
75. Strickland, D. K., Au, D. T., Cunfer, P., and Muratoglu, S. C. (2014). Low-density lipoprotein receptor-related protein-1: role in the regulation of vascular integrity. Arterioscler. Thromb. Vasc. Biol. 34, 487-498. doi: 10.1161/ATVBAHA.113.301924
76. Thevenard, J., Verzeaux, L., Devy, J., Etique, N., Jeanne, A., Schneider, C., et al. (2014). Low-density lipoprotein receptor-related protein-1 mediates endocytic clearance of tissue inhibitor of metalloproteinases-1 and promotes its cytokine-like activities. PLoS ONE 9:e103839. doi: 10.1371/journal.pone.0103839
77. Thompson, C. A., Purushothaman, A., Ramani, V. C., Vlodavsky, I., and Sanderson, R. D. (2013). Heparanase regulates secretion, composition, and function of tumor cell-derived exosomes. J. Biol. Chem. 288, 10093-10099. doi: 10.1074/jbc. C112.444562
78. Tian, X., Nyberg, S., Sharp, P. S., Madsen, J., Daneshpour, N., Armes, S. P., et al. (2015). LRP-1-mediated intracellular antibody delivery to the Central Nervous System. Sci. Rep. 5, 11990. doi: 10.1038/srep11990
79. Trommsdorff, M., Borg, J. P., Margolis, B., and Herz, J. (1998). Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J. Biol. Chem. 273, 33556-33560. doi: 10.1074/jbc.273.50.33556
80. Van Leuven, F., Cassiman, J. J., and Van Den Berghe, H. (1979). Demonstration of an a2-macroglobulin receptor in human fibroblasts, absent in tumor-derived cell lines. J. Biol. Chem. 254, 5155-5160.
81. Vreys, V., and David, G. (2007). Mammalian heparanase: what is the message? J. Cell. Mol. Med. 11, 427-452. doi: 10.1111/j.1582-4934.2007.00039.x
82. Vreys, V., Delande, N., Zhang, Z., Coomans, C., Roebroek, A., Dürr, J., et al. (2005). Cellular uptake of mammalian heparanase precursor involves low density lipoprotein receptor-related proteins, mannose 6-phosphate receptors, and heparan sulfate proteoglycans. J. Biol. Chem. 280, 33141-33148. doi: 10.1074/jbc. M503007200
83. Webb, D. J., Nguyen, D. H., and Gonias, S. L. (2000). Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion. J. Cell. Sci. 113(Pt 1), 123-134.
84. Yamamoto, K., Murphy, G., and Troeberg, L. (2015). Extracellular regulation of metalloproteinases. Matrix Biol. 44-46, 255-263. doi: 10.1016/j.matbio.2015.02.007
85. Yamamoto, K., Owen, K., Parker, A. E., Scilabra, S. D., Dudhia, J., Strickland, D. K., et al. (2014). Low density lipoprotein receptor-related protein 1 (LRP1)-mediated endocytic clearance of a disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4): functional differences of non-catalytic domains of ADAMTS-4 and ADAMTS-5 in LRP1 binding. J. Biol. Chem. 289, 6462-6474. doi: 10.1074/jbc. M113.545376
86. Yamamoto, M., Ikeda, K., Ohshima, K., Tsugu, H., Kimura, H., and Tomonaga, M. (1997). Increased expression of low density lipoprotein receptor-relatedprotein/a2-macroglobulin receptor in human malignant astrocytomas. Cancer Res. 57, 2799-2805.
87. Yang, J., Annala, M., Ji, P., Wang, G., Zheng, H., Codgell, D., et al. (2014). Recurrent LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell motility in human osteosarcoma. J. Hematol. Oncol. 7, 76. doi: 10.1186/s13045-014-0076-2
88. Zarebkohan, A., Najafi, F., Moghimi, H. R., Hemmati, M., Deevband, M. R., and Kazemi, B. (2015). Synthesis and characterization of a PAMAM dendrimer nanocarrier functionalized by SRL peptide for targeted gene delivery to the brain. Eur. J. Pharm. Sci. 78, 19-30. doi: 10.1016/j.ejps.2015.06.024